NO308077B1 - Substituert tiazol[3,2-a]azepinderivat, inhibitor, diuretikum og preparat omfattende derivatet, samt mellomprodukt - Google Patents

Substituert tiazol[3,2-a]azepinderivat, inhibitor, diuretikum og preparat omfattende derivatet, samt mellomprodukt

Info

Publication number
NO308077B1
NO308077B1 NO19961051A NO961051A NO308077B1 NO 308077 B1 NO308077 B1 NO 308077B1 NO 19961051 A NO19961051 A NO 19961051A NO 961051 A NO961051 A NO 961051A NO 308077 B1 NO308077 B1 NO 308077B1
Authority
NO
Norway
Prior art keywords
group
derivative
hydrogen atom
lower alkyl
diuretic
Prior art date
Application number
NO19961051A
Other languages
English (en)
Norwegian (no)
Other versions
NO961051D0 (no
NO961051L (no
Inventor
Hideyuki Adachi
Hitoshi Oinuma
Kazutoshi Miyake
Makoto Okita
Mamoru Saito
Masanori Mizuno
Naoki Yoneda
Shinji Suda
Toshiyuki Matsuoka
Makoto Kotake
Masayuki Namiki
Takeshi Sudo
Tomohiro Matsushima
Yoshio Fukuda
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6165481A external-priority patent/JPH0827156A/ja
Priority claimed from JP19918094A external-priority patent/JP3444666B2/ja
Priority claimed from JP6306468A external-priority patent/JPH08165293A/ja
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO961051D0 publication Critical patent/NO961051D0/no
Publication of NO961051L publication Critical patent/NO961051L/no
Publication of NO308077B1 publication Critical patent/NO308077B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO19961051A 1994-07-18 1996-03-14 Substituert tiazol[3,2-a]azepinderivat, inhibitor, diuretikum og preparat omfattende derivatet, samt mellomprodukt NO308077B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP6165481A JPH0827156A (ja) 1994-07-18 1994-07-18 アミノ酸誘導体の製造方法
JP19918094A JP3444666B2 (ja) 1994-08-24 1994-08-24 (2s, 3s)−3− メチル−2− チオペンタン酸誘導体の製造方法
JP6306468A JPH08165293A (ja) 1994-12-09 1994-12-09 置換チアゾロ[3,2−a]アゼピン誘導体
PCT/JP1995/001139 WO1996002549A1 (fr) 1994-07-18 1995-06-07 DERIVE DE THIAZOLO[3,2-α]AZEPINE A SUBSTITUTION

Publications (3)

Publication Number Publication Date
NO961051D0 NO961051D0 (no) 1996-03-14
NO961051L NO961051L (no) 1996-05-10
NO308077B1 true NO308077B1 (no) 2000-07-17

Family

ID=27322514

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19961051A NO308077B1 (no) 1994-07-18 1996-03-14 Substituert tiazol[3,2-a]azepinderivat, inhibitor, diuretikum og preparat omfattende derivatet, samt mellomprodukt

Country Status (17)

Country Link
US (2) US5789403A (es)
EP (1) EP0719779B1 (es)
KR (1) KR100284247B1 (es)
CN (2) CN1053908C (es)
AT (1) ATE254622T1 (es)
AU (1) AU694233B2 (es)
CA (1) CA2171334C (es)
DE (1) DE69532155T2 (es)
DK (1) DK0719779T3 (es)
ES (1) ES2210292T3 (es)
FI (2) FI110001B (es)
HU (1) HU225916B1 (es)
MX (1) MX9601017A (es)
NO (1) NO308077B1 (es)
NZ (1) NZ287557A (es)
PT (1) PT719779E (es)
WO (1) WO1996002549A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
WO1998034636A1 (fr) * 1997-02-05 1998-08-13 Suntory Limited Compositions medicinales pour traiter les cardiopathies induites par l'hypertrophie cardiaque
US9823092B2 (en) 2014-10-31 2017-11-21 Allegro Microsystems, Llc Magnetic field sensor providing a movement detector

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415496A (en) * 1981-03-23 1983-11-15 Merck & Co., Inc. Bicyclic lactams
ZA821904B (en) * 1981-03-23 1983-01-26 Merck & Co Inc Bicyclic lactams as anthihypertensives
US4617301A (en) * 1983-06-22 1986-10-14 Merck & Co., Inc. Sulfoxide and sulfone derivatives of bicyclic lactams as antihypertensives
JPS6056790A (ja) * 1983-09-03 1985-04-02 山陽科学株式会社 荷役用マット
RU2124503C1 (ru) * 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
CA2146238C (en) * 1992-10-30 2001-03-13 Gary A. Flynn Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors

Also Published As

Publication number Publication date
KR960704898A (ko) 1996-10-09
FI113656B (fi) 2004-05-31
PT719779E (pt) 2004-04-30
HU225916B1 (en) 2007-12-28
FI20011154A (fi) 2001-06-01
EP0719779B1 (en) 2003-11-19
NO961051D0 (no) 1996-03-14
DE69532155T2 (de) 2004-08-19
FI110001B (fi) 2002-11-15
WO1996002549A1 (fr) 1996-02-01
US6051705A (en) 2000-04-18
DE69532155D1 (de) 2003-12-24
CN1170832C (zh) 2004-10-13
CN1134152A (zh) 1996-10-23
ATE254622T1 (de) 2003-12-15
CA2171334C (en) 2008-10-21
AU694233B2 (en) 1998-07-16
NO961051L (no) 1996-05-10
KR100284247B1 (ko) 2001-10-24
EP0719779A1 (en) 1996-07-03
HUT76477A (en) 1997-09-29
NZ287557A (en) 1997-04-24
FI961199A (fi) 1996-05-13
DK0719779T3 (da) 2004-03-22
CN1262275A (zh) 2000-08-09
MX9601017A (es) 1997-10-31
CN1053908C (zh) 2000-06-28
ES2210292T3 (es) 2004-07-01
EP0719779A4 (en) 1996-12-18
CA2171334A1 (en) 1996-02-01
FI961199A0 (fi) 1996-03-14
HU9600679D0 (en) 1996-05-28
AU2630195A (en) 1996-02-16
US5789403A (en) 1998-08-04

Similar Documents

Publication Publication Date Title
AU1163492A (en) 3-benzylidene-1-carbamoyl-2-pyrrolidone analog
NO20001816D0 (no) Substituerte, kondenserte heterosykliske forbindelser
NO20004485D0 (no) Sykloalkenderivater, deres fremstilling og anvendelse
CO5011045A1 (es) Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos
CA2242242A1 (en) Quinolonecarboxylic acid derivatives or salts thereof
DE69814800D1 (de) Epoxysuccinamid-derivate oder ihre salze
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
ES2093091T3 (es) Derivado de glutation.
NO308077B1 (no) Substituert tiazol[3,2-a]azepinderivat, inhibitor, diuretikum og preparat omfattende derivatet, samt mellomprodukt
NZ304438A (en) Substituted triazole derivatives and antifungal compositions
ATE320417T1 (de) Naphthimidobenzamid-derivate
NO913769L (no) Forbindelse, fremstilling og anvendelse.
DE69629152D1 (de) Penem-derivate und sie enthaltende anti-mikrobische mittel
NO20004477L (no) Anvendelse av organiske karbonater for vasking av metalloverflater
TH13791EX (th) อนุพันธ์ต่างๆของกรดบิวไทริค

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: JK THORSENS PATENTBUREAU AS, POSTBOKS 9276 GRONLAN

MM1K Lapsed by not paying the annual fees